Anpario (LON:ANP) Stock Crosses Below Two Hundred Day Moving Average – Should You Sell?

Shares of Anpario plc (LON:ANP) crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of GBX 518.37 and traded as low as GBX 510. Anpario shares last traded at GBX 511.66, with a volume of 14,037 shares changing hands.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Shore Capital Group reissued a “house stock” rating on shares of Anpario in a research report on Monday, August 17th. Canaccord Genuity Group boosted their price target on shares of Anpario from GBX 570 to GBX 600 and gave the stock a “buy” rating in a report on Friday, September 11th. One research analyst has rated the stock with a Buy rating. According to data from MarketBeat, Anpario presently has an average rating of “Buy” and a consensus price target of GBX 600.

Anpario Stock Up 1.6%

The company has a quick ratio of 5.16, a current ratio of 6.29 and a debt-to-equity ratio of 0.60. The company has a market capitalization of £84.15 million, a PE ratio of 13.13 and a beta of 1.08. The stock has a 50-day moving average of GBX 507.10 and a 200 day moving average of GBX 518.37.

Anpario (LON:ANP) last issued its quarterly earnings results on Wednesday, September 9th. The company reported GBX 22.45 EPS for the quarter. Anpario had a return on equity of 17.05% and a net margin of 14.53%. Sell-side analysts anticipate that Anpario plc will post 23.58 EPS for the current year.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.